-
Negative Symptoms in Schizophrenia: An Observational Study of Patient Characteristics Cost and Healthcare Resource Utilization From a US Healthcare Database
Sep 9, 2025, 16:22 PM -
The Clinical Burden and Complications Associated With Glycogen Storage Disease Type Ia (GSDIa): Results From a Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Comorbidities and Comedication Among Individuals in Treatment for ADHD: A Danish Nationwide Study
Sep 9, 2025, 16:22 PM -
The Economic Burden of Inflammatory Arthritis: A Systematic Review
Sep 9, 2025, 16:22 PM -
Development of an Indicator-Based Framework for Epidemic Phase Classification in Emerging Respiratory Infectious Diseases
Sep 9, 2025, 16:22 PM -
Systematic Literature Review on the Burden and Economic Impact of Invasive Meningococcal Disease in Adolescents and Young Adults in the UK
Sep 9, 2025, 16:22 PM -
Estimating the Cost-Effectiveness of Tumor-Treating Fields With Gemcitabine and Nabpaclitaxel for Frontline Treatment of Locally Advanced Pancreatic Adenocarcinoma
Sep 9, 2025, 16:22 PM -
Socioeconomic Burden Among Children and Adults With Achondroplasia in Europe and Latin America
Sep 9, 2025, 16:22 PM -
European and US Drug Shortages: A Critical Analysis of Key Trends and Causes
Sep 9, 2025, 16:22 PM -
Development of a Partitioned Survival Model Template for Oncology Indications: A Flexible and Customizable Framework
Sep 9, 2025, 16:22 PM -
Consideration of Off-Label Therapies as Appropriate Comparator Therapy in Early Benefit Assessments in Germany Under the ALBVVG Legislation
Sep 9, 2025, 16:22 PM -
The Economic Burden of Moderate and Severe Anxiety and Depression Symptoms in Saudi Arabia
Sep 9, 2025, 16:22 PM -
Healthcare Costs of Mammography Screening and Breast Cancer Treatment: A Registry-Based Study From Norway
Sep 9, 2025, 16:22 PM -
What Drives European Union (EU) Health Technology Assessment (HTA) Decisions in Melanoma? A Targeted Review on Clinical Evidence Critiques
Sep 9, 2025, 16:22 PM -
Real-World Evidence of Atezolizumab in Unresectable Recurrent NSCLC: Insights From Japan's Next-Generation Medical Infrastructure Act
Sep 9, 2025, 16:22 PM -
Real-World Evidence Study on Healthcare Resource Utilization (HCRU) Among Cancer Patients in the Helsinki and Uusimaa (HUS) Region, Finland
Sep 9, 2025, 16:22 PM -
Exploring LLMs in the Conceptual and Functional Construction of Health Economic Models: A Case Study on Alzheimer's Diagnostic Cost-Effectiveness Model
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of Adding Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors or Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists to Standard Therapy in Thai Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease
Sep 9, 2025, 16:22 PM -
An Adjusted Indirect Comparison of Once-Weekly Insulin Efsitora Alfa vs. Insulin Icodec for Adults With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin
Sep 9, 2025, 16:22 PM -
Use of Big Data to Assess Dyslipidemia Management in Greece: Real-World Insights From the National Healthcare Payer
Sep 9, 2025, 16:22 PM
